{
  "meta": {
    "title": "Antiviral_Antimalarial_Antineoplastic_Agents",
    "url": "https://brainandscalpel.vercel.app/antiviral-antimalarial-antineoplastic-agents-139bd3fa.html",
    "scrapedAt": "2025-11-30T08:50:49.444Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Anemia and neutropenia</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinal detachment</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Cataract</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Sexual dysfunction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 31-year-old man with AIDS was recently diagnosed with cytomegalovirus pneumonia. The patient's current medications included zidovudine, didanosine and atazanavir. Intravenous therapy with ganciclovir was started. Which of the following adverse effects would be predicted to be most likely to occur due to the concurrent administration of ganciclovir and the antiretroviral drugs?</span></p>",
      "unique_key": "DT1293320",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293320,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em><u>Ganciclovir is a drug of choice for cytomegalovirus (CMV) infections. </u></em></p>\r\n<p><em><u>The dose-limiting toxicity of both zidovudine and ganciclovir is bone marrow suppression; <strong>therefore, anemia and neutropenia can be predicted from the concurrent administration of ganciclovir and zidovudine.</strong></u></em></p>\r\n<p><strong><em>Systemic toxicity of ganciclovir is high </em></strong></p>\r\n<ul>\r\n<li><em>Bone marrow</em><em> suppression </em></li>\r\n<li><em>Fever</em><em>, Rash</em></li>\r\n<li><em>Vomiting </em></li>\r\n<li><em>Neuropsychiatric disturbances</em></li>\r\n<li><em>Retinal Detachments &amp; Cataract if used Intravitreal.</em></li>\r\n</ul>\r\n<p>Therefore, <em><u>use is restricted to prophylaxis and treatment of severe CMV infections (pneumonia/colitis/retinitis) which occur in immunocompromised (AIDS, transplant recipient) patients</u></em>. <br><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122335344f4d-6f50-46ad-b9d1-bfd6622cead1.jpg\">\r\n<p><strong>Option B &amp; C</strong>: <strong>Retinal detachment and cataracts </strong>are adverse effects of ganciclovir that can occur <strong>following intravitreal </strong>administration of the drug for CMV retinitis. They <strong>do not occur </strong>when the drug is administered <strong>intravenously</strong> for systemic anti-CMV therapy.</p>\r\n<p><strong>Option D: Sexual dysfunction is not an adverse effect </strong>of the drugs the patient has been receiving.</p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>The dose-limiting toxicity of ganciclovir is <strong>bone marrow suppression, </strong>hence manifested as <strong>anemia and neutropenia if administered along with zidovudine. </strong></em></li>\r\n</ul>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Azidothymidine</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Indinavir</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Ketoconazole</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Sulfamethoxazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56 year old male patient with AIDS was being treated with multiple drugs, including AZT, lamivudine, indinavir, ketoconazole and cotrimoxazole. Later he came to the medicine department with breast hypertrophy, central adiposity, hyperlipidemia, insulin resistance, and nephrolithiasis. If these side effects are related to his drug treatment, which of the following is the most likely implicated drug?</span></p>",
      "unique_key": "DT1293501",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293501,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412238383c519-8961-4a3f-b6e1-ef062736bf94.jpg\">\r\n<ul>\r\n<li><em>Indinavir, <strong>a protease inhibitor </strong>causes the above given adverse effects.</em></li>\r\n<li><em>AIDS patients being treated with protease inhibitors (eg, <strong>indinavir</strong>) have developed a <strong>syndrome involving derangement of lipid metabolism</strong>.</em></li>\r\n<li><em>This causes changes in <strong>body fat distribution and type 2 diabetes</strong> has also been reported. It is often referred to as <strong>HIV/HAART-associated lipodystrophy</strong>.</em></li>\r\n<li><em>It is typically <strong>seen after 6-12 months</strong> of protease inhibitor therapy.</em></li>\r\n<li><em>Indinavir is also notable for its tendency to <strong>precipitate in the urinary tract, causing nephrolithiasis</strong>, unless the patient is maintained in a high state of hydration.</em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412232dffceaf-d53c-4446-946d-374da207b47e.jpg\">\r\n<ul>\r\n<li><strong>Option A<em>: </em></strong><em>Major adverse effect of zidovudine is <strong>bone marrow suppression </strong>leading to megaloblastic anemia, neutropenia and thrombocytopenia.</em></li>\r\n<li><strong>Option C<em>: </em></strong><em>Inhibition of CYP enzymes by ketoconazole result in decreased formation of adrenal and gonadal steroids and may lead to <strong>gynaecomastia, menstrual irregularities and infertility.</strong></em></li>\r\n<li><strong>Option D<em>: </em></strong><em>Sulfonamides can displace bilirubin from plasma protein binding sites and may result in <strong>unconjugated hyperbilirubinemia and kernicterus in the newborn.</strong></em></li>\r\n</ul>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>AIDS patients being treated with protease inhibitors (eg, indinavir) develops <strong>derangement of lipid metabolism (HIV/HAART-associated lipodystrophy).</strong></em></li>\r\n</ul>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Amantadine</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Valacyclovir</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Vidarabine</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Foscarnet</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old immunocompetent woman sees her family physician with painful \"bumps\" on her labia and vulva. On examination, there are vesicles in the described region. You suspect herpes simplex infection on clinical grounds and recommend which of the following?</span></p>",
      "unique_key": "DT1293503",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293503,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em><u>Valacyclovir is related to acyclovir, both of which are used for the treatment of oral and genital herpes in immunocompetent individuals.</u></em></p>\r\n<ul>\r\n<li><strong><em><u>Valacyclovir :</u></em></strong></li>\r\n<li><em>It is a <strong>valyl ester prodrug of acyclovir with improved oral bioavailability</strong></em> <em>due to active transport by peptide transporters in the intestine.</em></li>\r\n<li><em>During passage through intestine and liver, it is <strong>completely converted to acyclovir </strong>in the first passage by esterases</em><em>. Valaciclovir is <strong>excreted in urine.</strong></em></li>\r\n<li><strong><em>Thus, &gt;3 fold higher plasma levels of acyclovir </em></strong><em>are obtained improving clinical efficacy in certain conditions</em><em>.</em></li>\r\n<li><strong><em>It is the drug of choice in herpes zoster.</em></strong></li>\r\n</ul>\r\n<p><strong><em>Option A, C &amp; D</em></strong><em>: All of these agents are not the preferred choice of drugs for herpes zoster.</em></p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Valacyclovir is used for the treatment of <strong>oral and genital herpes in immunocompetent individuals</strong>.</em></li>\r\n</ul>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Foscarnet</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Ribavirin</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Ganciclovir</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Acyclovir</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 33-year-old woman with AIDS was recently diagnosed with cytomegalovirus retinitis. The ophthalmologist prescribed a drug that must be phosphorylated first by virus-specific enzymes, then by host cell enzymes to become active. Which of the following drugs was most likely given?</span></p>",
      "unique_key": "DT1293504",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293504,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong><em><u>Ganciclovir and acyclovir </u></em></strong><em><u>are nucleoside analogues that <strong>must be phosphorylated</strong> first by virus-specific enzymes</u></em><em>.</em></li>\r\n<li><em>Both drugs are phosphorylated by a <strong>viral thymidine kinase in herpes simplex virus (HSV)-infected cells.</strong></em></li>\r\n<li><em><u>Ganciclovir</u></em><em><u> is also phosphorylated by a </u></em><em><u>specific viral phosphotransferase in cytomegalovirus (CMV)&minus;infected cells</u></em><em>.</em></li>\r\n<li><em>This explains why <strong>both drugs are active against HSV, but only ganciclovir is effective against CMV</strong>.</em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223d784b563-59a8-404e-88e6-102abc9d9f3d.jpg\">\r\n<p><strong><em>Systemic toxicity of ganciclovir is high </em></strong></p>\r\n<ul>\r\n<li><em>Bone marrow suppression </em></li>\r\n<li><em>Rash</em></li>\r\n<li><em>Fever </em></li>\r\n<li><em>Vomiting </em></li>\r\n<li><em>Neuropsychiatric disturbances</em></li>\r\n</ul>\r\n<p>Therefore, <em><u>use is restricted to prophylaxis and treatment of severe CMV infections (pneumonia/colitis/retinitis) which occur in immunocompromised (AIDS, transplant recipient) patients</u></em>.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412239522a6fd-cf3d-474b-b739-ed1e7013eaf0.jpg\">\r\n<p><strong><em>Option A, B &amp; D: </em></strong><em>All of these given agents are not effective against CMV retinitis. Hence not preferred. </em></p>\r\n<p><strong><u>Key Takeaway:</u></strong></p>\r\n<ul>\r\n<li><em>Ganciclovir is a nucleoside analogue that is activated by a<strong> specific viral phosphotransferase</strong> in cytomegalovirus (CMV)-infected cells.</em></li>\r\n</ul>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloroquine</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Metronidazole</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Iodoquinol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman complained to his physician of a sudden increase in her heart rate. Four days earlier, the woman, who had recently returned from a trip to Uganda, was hospitalized with the presumptive diagnosis of malaria. The Plasmodium vivax infection was confirmed, and the patient started an appropriate therapy. An electrocardiogram led to the diagnosis of torsades de pointes. Which of the following drugs most likely caused the patient's arrhythmia?</span></p>",
      "unique_key": "DT1293505",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293505,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><em>The <u>patient was most likely treated with <strong>chloroquine</strong>, a quinoline derivative that is a first-line agent for Plasmodium vivax and P. ovale infections</u>.</em></li>\r\n<li><strong><em>All <u>quinolines can prolong the QT interval</u></em></strong><em><u> on an electrocardiogram, increasing the risk of torsades de pointes</u></em><em>.</em></li>\r\n<li><em>The arrhythmia is rare, but<strong> its occurrence may be increased in patients already at risk because of a concomitant disease.</strong></em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122392636f21-a613-43fa-8966-13da79c57d4c.jpg\">\r\n<ul>\r\n<li><strong>Option A, C &amp; D</strong>: <em>All given agents are not associated with development of arrhythmias as they don't prolong QT interval.</em></li>\r\n</ul>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>All quinolines can <strong>prolong the QT interval </strong>on an electrocardiogram, increasing the risk of torsades de pointes.</em></li>\r\n</ul>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoglycemia</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac failure</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Arrhythmias</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypotension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27 year old pregnant female living in an endemic area presented to the medicine department with complaints of high grade fever, headache, abdominal pain, hematuria and extreme fatigue. She was diagnosed of having severe falciparum malaria and she was being administered i.v. quinine following which she developed restlessness and sweating. Which of the following is the most likely side effect produced by quinine? </span></p>",
      "unique_key": "DT1293552",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293552,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><em><u>Cinchonism</u></em></strong><em><u> :</u></em></p>\r\n<ul>\r\n<li><em>A large single dose or <u>higher therapeutic doses taken for a few days produce a syndrome called 'cinchonism'</u>.</em></li>\r\n<li><em>It consists of</em>\r\n<ul>\r\n<li><strong><em>Ringing in ears</em></strong></li>\r\n<li><strong><em>Nausea, vomiting (due to both gastric irritation and CTZ stimulation)</em></strong></li>\r\n<li><strong><em>Headache</em></strong></li>\r\n<li><strong><em>Mental confusion</em></strong></li>\r\n<li><strong><em>Vertigo </em></strong></li>\r\n<li><strong><em>Difficulty in hearing and visual defects (due to direct neurotoxicity as well as constriction of retinal and auditory vessels)</em></strong></li>\r\n</ul>\r\n</li>\r\n<li><em>Diarrhoea, flushing and marked perspiration</em></li>\r\n<li><em>Delirium, fever, tachypnoea followed by respiratory depression, pulmonary edema, hypoglycaemia, marked weakness and prostration can occur.</em></li>\r\n<li><strong><em>Hypotension, cardiac arrhythmias (Q-T prolongation ) develop only on rapid i.v. injection</em></strong></li>\r\n<li><em><u>Quinine occasionally causes haemolysis, especially in pregnant women and in patients of falciparum malaria, resulting in haemoglobinuria (black water fever) and kidney damage</u></em><em>.</em></li>\r\n<li><em><u>During pregnancy it should be used only for serious falciparum malaria, with special care to prevent hypoglycemia</u></em><em>.</em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122419d97e86-9554-4eac-bc80-bee6a053a451.jpg\">\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Quinine can cause hypoglycemia manifested by palpitations, sweating and tachycardia. <strong><u>To prevent hypoglycemia, i.v. infusion of quinine should always be given in 5% dextrose solution (instead of normal saline).</u></strong></em></li>\r\n</ul>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral Primaquine</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Injection Quinine</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous artesunate</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral Chloroquine, sulfadoxine, pyrimethamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30 year old male patient had a travel history of Assam. After coming back he developed high grade fever with chills and rigors presented to the emergency department with hematuria and altered sensorium. The peripheral smear demonstrated the presence of P.falciparum. Which of the following treatments should be immediately started to the patient? </span></p>",
      "unique_key": "DT1293562",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293562,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong><em><u>Severe and complicated falciparum malaria</u></em></strong>\r\n<ul>\r\n<li><em><u>Parenteral artemisinins are highly effective and are the drugs of choice irrespective of CQ resistance status</u></em><em>.</em></li>\r\n<li><em>Quinine is used only as an alternative when artemisinins cannot be used.</em></li>\r\n<li><em>Quinine (i.v.) continues to be the drug used for severe falciparum malaria during 1st trimester of pregnancy, because safety of artemisinins is not yet proven.</em></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412243e7f55f5-8884-49fc-b932-45e4bb03dde1.jpg\">\r\n<ul>\r\n<li><strong><em><u>Severe and complicated falciparum malaria</u></em></strong>\r\n<ul>\r\n<li><strong><em>Parenteral artemisinins are highly effective and are the drugs of choice</em></strong></li>\r\n<li><em><u>Quinine infused i.v. had been the drug of choice for severe and complicated malaria</u></em><em>, including cerebral malaria, but <u>now i.v./i.m. artemisinins are preferred, while quinine is used only as an alternative when artemisinins cannot be used.</u></em></li>\r\n</ul>\r\n</li>\r\n<li><strong><em><u>Artesunate (i.v.) offers several advantages:</u></em></strong>\r\n<ul>\r\n<li><strong><em>It causes faster parasite clearance than i.v. quinine.</em></strong></li>\r\n<li><strong><em>It is safer and better tolerated than i.v. quinine.</em></strong></li>\r\n<li><strong><em>Its dosing schedule is simpler.</em></strong></li>\r\n<li><strong><em>Evidence from clinical trial indicates higher efficacy and lower mortality</em></strong><strong>.</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Options A, B &amp; D</strong>: <em>All given agents are not the preferred choice of drugs for Severe and complicated falciparum malaria. All are primarily preferred for P.vivax infections</em></p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Parenteral artemisinins are highly effective and are the drugs of choice for <u>Severe and complicated falciparum malaria</u></em></li>\r\n</ul>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Metronidazole</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Nifurtimox</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Suramin</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Mebendazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 14-year-old boy returns from a hiking trip with foul-smelling watery diarrhea. On further questioning, he admits to drinking water from a mountain source without first boiling it. Stool is sent for ova and parasites, confirming the diagnosis of Giardia lamblia infection. Which of the following drugs is appropriate treatment?</span></p>",
      "unique_key": "DT1293564",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293564,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><em><u>Metronidazole is used to treat protozoal infections due to Giardia, Entamoeba, and Trichomonas spp.</u></em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412245af72c2f-caa6-4269-b3c9-a9c6bcbf38f9.jpg\">\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412248180feab-455f-40cd-9e19-64585311606e.jpg\">\r\n<p><strong>Option B</strong>: Nifurtimox is used to treat Chagas disease (due to<em> Trypanosoma cruzii</em>).</p>\r\n<p><strong>Option C</strong>: Suramin is used to treat African trypanosomiasis.</p>\r\n<p><strong>Option D</strong>: Mebendazole is used to treat round worm infections</p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Metronidazole is used to treat protozoal infections due to Giardia, Entamoeba, and Trichomonas spp.</em></li>\r\n</ul>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Purine phosphoribosyltransferase</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Ornithine decarboxylase</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferredoxin oxidoreductase</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Dihydrofolate reductase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man with AIDS was admitted to the hospital with the preliminary diagnosis of pneumonia. Further tests led to the diagnosis of toxoplasmosis, and an appropriate combination therapy was started. Inhibition of which of the following protozoal enzymes most likely mediated the therapeutic effect of the therapy in this patient?</span></p>",
      "unique_key": "DT1293567",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293567,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><em>The <strong>patient most likely received a sulfadiazine&minus;pyrimethamine combination that represents the standard therapy for toxoplasmosis.</strong></em></li>\r\n<li><em><u>Pyrimethamine selectively inhibits protozoal dihydrofolate reductase, a key enzyme for folate biosynthesis in the parasite</u></em><em>.</em></li>\r\n<li><em>This in turn leads to failure in DNA synthesis and nuclear division.</em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241224e3dd8baf-3799-477a-ad48-11260a62e614.jpg\">\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Pyrimethamine selectively inhibits protozoal dihydrofolate reductase, a key enzyme for folate biosynthesis in the parasite.</em></li>\r\n</ul>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluconazole</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Metronidazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28 years old female in her 3rd trimester of pregnancy presented to her gynecologist with foul smelling greenish vaginal discharge. On investigation there were clue cells on histopathology and whiff test was positive in vaginal discharge. Which of the following is the drug of choice for this condition? </span></p>",
      "unique_key": "DT1293581",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293581,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><em><u>The diagnosis is <strong>Trichomonas vaginitis</strong>.</u></em></li>\r\n<li><em><u>The drug of choice is metronidazole (2.0 g single dose is preferred.) or Tinidazole.</u></em></li>\r\n<li><em><u>Metronidazole is used to treat protozoal infections due to Giardia, Entamoeba, and Trichomonas spp.</u></em></li>\r\n<li><em><u>The male partner should be treated concurrently in cases of recurrent infections.</u></em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241224d443f2dc-1fa0-4147-9a3c-0eab3ce93b81.jpg\">\r\n<p><strong>Options A, B &amp; C</strong>: <em>All given agents is not preferred choice of drugs for trichomonas vaginitis as they are not that much effective as metronidazole</em></p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Metronidazole is used to treat protozoal infections due to Giardia, Entamoeba, and Trichomonas spp.</em></li>\r\n</ul>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclophosphamide</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxorubicin</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Prednisone</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Vincristine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 47-year-old man with non-Hodgkin lymphoma was admitted to the hospital to receive his fourth cycle of CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) regimen plus rituximab. Physical examination revealed tachycardia, shortness of breath that worsened on lying, neck vein distention, pulmonary rales and ankle edema. Which of the following drugs most likely caused these adverse effects?</span></p>",
      "unique_key": "DT1293588",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293588,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><em>In the CHOP acronym, </em></li>\r\n<li><em><u>C stands for <strong>cyclophosphamide</strong>; </u></em></li>\r\n<li><em><u>H for hydroxydaunorubicin, which is another name for <strong>doxorubicin</strong>;</u></em></li>\r\n<li><em><u>O is for <strong>Oncovin</strong>,</u></em></li>\r\n<li><em><u>P is for prednisone or <strong>prednisolone</strong></u></em><em>.</em></li>\r\n<li><em>The CHOP regimen has been considered the best treatment for the initial therapy of patients with diffuse non-Hodgkin lymphoma.</em></li>\r\n<li><em><u>The signs and symptoms of the patient suggest the diagnosis of <strong>cardiac failure.</strong></u></em></li>\r\n<li><strong><em>Anthracyclines (doxorubicin, daunorubicin, idarubicin, etc.) are the anticancer drugs that have the highest risk of cardiac toxicity</em></strong><em>.</em></li>\r\n<li><em>They <strong><u>can cause a dose dependent dilated cardiomyopathy associated with a potentially fatal cardiac failure</u>.</strong></em></li>\r\n<li><em><u>This toxicity appears to result <strong>from increased production of free radicals</strong> within the myocardium</u></em><em>.</em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412244e96c402-96e7-4695-8c38-1ada126b66ef.jpg\">\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122498257a39-ed19-4184-9553-6896da502ec8.jpg\">\r\n<p><strong>Option A</strong><em>: Cyclophosphamide results in <strong>hemorrhagic cystitis, </strong>cardiac dysfunction, pulmonary toxicity and syndrome of inappropriate ADH secretion</em></p>\r\n<p><strong>Option C</strong><em>: Prednisone is associated with a range of side effects including opportunistic infection but it is <strong>not cardiotoxic.</strong></em></p>\r\n<p><strong>Option D</strong><em>: Vincristine is associated with development of <strong>peripheral neuropathy</strong> in the first few weeks of therapy characterised by paresthesias and loss of reflexes.</em></p>\r\n<p><strong><u>Key takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Doxorubicin is the Anthracycline anticancer drug that has the highest risk of cardiac toxicity, it can cause a <strong>dose dependent dilated cardiomyopathy associated with a potentially fatal cardiac failure.</strong></em></li>\r\n</ul>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Vincristine</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Prednisone</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Mercaptopurine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old man complained of numbness in his fingers and the soles of his feet. Three weeks previously, he had started chemotherapy for acute lymphoblastic leukemia. Physical examination showed loss of ankle jerk and depression of deep tendon reflexes. Which of the following drugs most likely caused the patient's signs and symptoms?</span></p>",
      "unique_key": "DT1293592",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293592,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em><u>The patient's paresthesias and loss of reflexes are signs of vincristine peripheral neuropathy, which often appears within the first few weeks of therapy. </u></em></p>\r\n<p><em>Areflexia is common in patients treated with high cumulative doses. </em></p>\r\n<p><strong><em>Vincristine</em></strong><em> causes a <strong>dose-limiting neurotoxicity</strong> but is a mild myelosuppression , whereas <strong>vinblastine</strong> causes negligible neurotoxicity but gives rise to a severe, dose-limiting <strong>myelosuppression</strong>.</em></p>\r\n<p>Vin<strong>C</strong>ristine - <strong>C</strong>NS</p>\r\n<p>Vin<strong>B</strong>Lastine - <strong>Blast </strong>Cell Arrest.</p>\r\n<ul>\r\n<li><strong><em><u>Vincristine (oncovin)</u></em></strong>\r\n<ul>\r\n<li><em>It is a rapidly acting drug, <u>very useful for inducing remission in <strong>childhood acute lymphoblastic leukaemia.</strong></u></em></li>\r\n</ul>\r\n</li>\r\n<li><em>Other indications are</em>\r\n<ul>\r\n<li><strong><em>Acute myeloid leukaemia, </em></strong></li>\r\n<li><em>Hodgkin's disease,</em></li>\r\n<li><em>Wilms' tumour, </em></li>\r\n<li><em>Ewing's sarcoma, </em></li>\r\n<li><em>Neuroblastoma</em></li>\r\n<li><em>Carcinoma lung.</em></li>\r\n</ul>\r\n</li>\r\n<li><strong><em><u>Prominent adverse effects</u></em></strong>\r\n<ul>\r\n<li><strong><em>Peripheral neuropathy </em></strong></li>\r\n<li><em>Ataxia, </em></li>\r\n<li><em>Nerve palsies, </em></li>\r\n<li><strong><em>Autonomic dysfunction </em></strong></li>\r\n<li><em>(postural hypotension, paralytic ileus, urinary retention)</em></li>\r\n<li><em>Bone marrow depression</em></li>\r\n<li><strong><em>Syndrome of inappropriate secretion of ADH (SIADH) can occur</em></strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122492613cce-09ee-483d-b203-66a5bb04e4aa.jpg\">\r\n<p><strong>Option B</strong><em>: Prednisone is associated with range of side effects including <strong>opportunistic infection </strong>but not peripheral neuropathy</em></p>\r\n<p><strong>Option C<em>: </em></strong><em>Adverse effects of methotrexate <strong>are bone marrow suppression and mucositis.</strong></em></p>\r\n<p><strong>Option D<em>: </em></strong><em>Dose limiting toxicity of 6-mercaptopurine (6-MP) is <strong>bone marrow suppression but hepatotoxicity can also result.</strong></em></p>\r\n<p><strong><u>Key takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Vincristine is associated with <strong>development of peripheral neuropathy</strong> in the first few weeks of therapy characterised by paresthesias and loss of reflexes.</em></li>\r\n</ul>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Cisplatin </span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Vincristine </span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Capecitabine </span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitomycin-C </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56 year old patient developed the following lesions after 10 days of treatment. Patient also complain of similar lesions over soles and they are sensitive to touch. The most likely agent to cause that adverse effect is?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/1fb8c9f53-d422-4a5d-a794-37a9cf4dd5af6.jpg\"></span></p>",
      "unique_key": "DT1293601",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293601,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong><em>Hand foot syndrome or palmar-plantar erythrodysesthesia</em></strong><em> consists of <strong>erythema, desquamation, pain and sensitivity to touch of the palms and soles</strong>.</em></li>\r\n<li><strong><em><u>Drugs commonly implicated are:</u></em></strong>\r\n<ul>\r\n<li><strong><em>Capecitabine</em></strong></li>\r\n<li><strong><em>5-Fluorouracil</em></strong></li>\r\n<li><strong><em>Cytarabine</em></strong></li>\r\n<li><strong><em>Pemetrexed</em></strong></li>\r\n<li><strong><em>Doxorubicin</em></strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Option A:</strong><em> Cisplatin is associated with <strong>nausea and vomiting </strong>(maximum among all anti-cancer drugs). It is mild bone marrow suppressants and are nephrotoxic, ototoxic as well as neurotoxic.</em></p>\r\n<p><strong>Option B</strong><em>: Vincristine is associated with development <strong>of peripheral neuropathy</strong> in first few weeks of therapy characterised by paresthesias and loss of reflexes</em></p>\r\n<p><strong>Option D</strong><em>: Mitomycin C is associated with bone marrow and g.i.t. are the primary targets of toxicity. <strong>Myelosuppression is typically delayed.</strong> A haemolytic-uremic syndrome is reported.</em></p>\r\n<p><strong><u>Key takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Capecitabine is associated with <strong>Hand foot syndrome or palmar-plantar erythrodysesthesia</strong></em></li>\r\n</ul>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Cisplatin</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Cytarabine</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Bleomycin</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Actinomycin D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45 year old male patient with a history of blood leukemia with mild renal impairment came to an oncologist for treatment and had given some high dose of an anti-cancer agent following which he developed ataxia, slurred speech with megaloblastic anaemia. Which amongst the following anticancer agents is associated with Cerebellar toxicity? </span></p>",
      "unique_key": "DT1293603",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293603,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><em><u>Adverse Effects of Cytarabine</u></em></strong></p>\r\n<ul>\r\n<li><strong><em>Cytarabine is myelosuppressive and can produce acute, severe leukopenia, thrombocytopenia, and anemia with striking megaloblastic changes.</em></strong></li>\r\n<li><em><u>Other toxic manifestations include </u></em>\r\n<ul>\r\n<li><em>GI disturbances</em></li>\r\n<li><em>Stomatitis</em></li>\r\n<li><em>Conjunctivitis</em></li>\r\n<li><em>Reversible hepatic enzyme elevations </em></li>\r\n<li><em>Noncardiogenic pulmonary edema</em></li>\r\n<li><em>Dermatitis</em></li>\r\n</ul>\r\n</li>\r\n<li><em>The onset of dyspnea, fever, and pulmonary infiltrates on chest computed tomographic scans may follow 1-2 weeks after high-dose.</em></li>\r\n<li><strong><em>Cerebellar toxicity, manifesting as ataxia and slurred speech</em></strong></li>\r\n<li><strong><em><u>Cerebral toxicity (seizures, dementia, and coma) may follow intrathecal administration or high-dose systemic administration, especially in patients older than 40 years or patients with poor renal function</u></em></strong><strong><em>.</em></strong></li>\r\n</ul>\r\n<p><strong>Option A: </strong><em>Cisplatin is associated with <strong>nausea and vomiting </strong>(maximum among all anti-cancer drugs). It is mild bone marrow suppressants and are nephrotoxic, ototoxic as well as neurotoxic.</em></p>\r\n<p><strong>Option C: </strong><em>Bleomycin results in <strong>cutaneous toxicity </strong>(hyperpigmentation, hyperkeratosis, erythema and ulcers), pneumonitis, <strong>pulmonary fibrosis</strong>, hypersensitivity and mucocutaneous reactions (particularly <strong>flagellated pigmentation of skin).</strong></em></p>\r\n<p><strong>Option D: </strong><em>Prominent adverse effects of Actinomycin D are vomiting, stomatitis, diarrhoea, erythema and <strong>desquamation of skin, alopecia and bone marrow depression.</strong></em></p>\r\n<p><strong><u>Key takeaway</u></strong></p>\r\n<ul>\r\n<li><strong><em>Cerebellar toxicity </em></strong><em>may follow intrathecal administration or high-dose systemic administration of Cytarabine, manifesting as <strong>ataxia and slurred speech.</strong></em></li>\r\n</ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Bleomycin</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitomycin C</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxorubicin</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Actinomycin D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54 year old patient with a history of having some form of cancer & prescribed anti-cancer medicines for the same. Which of the following drugs can cause the side-effects given in the picture below? <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/1fbc74976-0f01-4335-a643-64af5e5acc5e7.jpg\"></span></p>",
      "unique_key": "DT1293605",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293605,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><em><u>Bleomycin :</u></em></strong></p>\r\n<ul>\r\n<li><em>It is a glycopeptide drug that acts in the <strong>G2 phase</strong> by causing DNA strand breakage and free radical formation.</em></li>\r\n<li><em>It can result in</em>\r\n<ul>\r\n<li><strong><em><u>Cutaneous toxicity</u></em></strong><em><u> (hyperpigmentation, hyperkeratosis, erythema and ulcers), pneumonitis, </u></em></li>\r\n<li><strong><em><u>Pulmonary fibrosis,</u></em></strong></li>\r\n<li><em><u>Hypersensitivity and </u></em></li>\r\n<li><strong><em><u>Mucocutaneous reactions (particularly flagellated pigmentation of skin).</u></em></strong></li>\r\n</ul>\r\n</li>\r\n<li><strong><em><u>It causes necrosis of type I pneumocytes </u></em></strong><em><u>that results in compensatory hyperplasia of type II pneumocytes.</u></em></li>\r\n<li><em><u>Bleomycin is metabolized by <strong>bleomycin hydrolase</strong>, whose concentration is less in skin and lungs (thus major organs involved in toxicity).</u></em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/13f8c2cb2-06ef-4b34-be62-4692caad020d8.jpg\">\r\n<p><strong>Option B</strong><em>: Mitomycin C is associated with bone marrow and g.i.t. are the primary targets of toxicity. <strong>Myelosuppression is typically delayed. A haemolytic-uremic syndrome is reported.</strong></em></p>\r\n<p><strong>Option C</strong>: <em>Doxorubicin is the Anthracycline anticancer drug that has the highest risk of cardiac toxicity, it can cause <strong>a dose dependent dilated cardiomyopathy associated with a potentially fatal cardiac failure.</strong></em></p>\r\n<p><strong>Option D: </strong><em>Prominent adverse effects of Actinomycin D are vomiting, stomatitis, diarrhoea, erythema and <strong>desquamation of skin, alopecia and bone marrow depression.</strong></em></p>\r\n<p><strong><u>Key takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Bleomycin results in <strong>cutaneous toxicity</strong> (hyperpigmentation, hyperkeratosis, erythema and ulcers), pneumonitis, pulmonary fibrosis, hypersensitivity and <strong><u>mucocutaneous reactions (particularly flagellated pigmentation of skin).</u></strong></em></li>\r\n</ul>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclophosphamide</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxorubicin</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Vincristine</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Bleomycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man was admitted to the hospital with fever, dyspnea and nonproductive cough. Two weeks earlier, the patient had completed five courses of chemotherapy with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin for large-cell lymphoma. Chest x-ray showed diffuse bilateral infiltrates and a lung biopsy revealed inflammation and fibrosis with no evidence of lymphoma. Which of the drugs administered to the patient most likely caused his pulmonary disorder?</span></p>",
      "unique_key": "DT1293610",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293610,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em><u>Among the anticancer drugs, bleomycin most commonly causes pulmonary toxicity, mainly interstitial pneumonitis followed by pulmonary fibrosis. </u></em></p>\r\n<p><em><u>The mortality associated with bleomycin pulmonary toxicity is very high (about 50%).</u></em></p>\r\n<p><strong><em><u>Bleomycin</u></em></strong></p>\r\n<ul>\r\n<li><em>It is a glycopeptide drug that acts in the<strong> G2 phase</strong> by causing DNA strand breakage and free radical formation.</em></li>\r\n<li><em>It can result in :</em>\r\n<ul>\r\n<li><strong><em>Cutaneous toxicity </em></strong><em>(hyperpigmentation, hyperkeratosis, erythema and ulcers)</em></li>\r\n<li><strong><em>Pneumonitis</em></strong></li>\r\n<li><strong><em>Pulmonary fibrosis, </em></strong></li>\r\n<li><em>Hypersensitivity and </em></li>\r\n<li><strong><em>Mucocutaneous reactions </em></strong><em>(particularly flagellated pigmentation of skin).</em></li>\r\n</ul>\r\n</li>\r\n<li><strong><em>It causes necrosis of type I pneumocytes that results in compensatory hyperplasia of type II pneumocytes.</em></strong></li>\r\n<li><strong><em>Bleomycin is metabolized by bleomycin hydrolase, whose concentration is less in skin and lungs (thus major organs involved in toxicity). <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/b8e58c25-0df7-4551-b193-3eb3b1be06491.jpg\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2249d6b49-ad29-490e-a881-54115fde51b00.jpg\"></em></strong></li>\r\n</ul>\r\n<p><strong>Option A</strong><em>: Cyclophosphamide results in <strong>hemorrhagic cystitis, </strong>cardiac dysfunction, pulmonary toxicity and syndrome of inappropriate ADH secretion</em></p>\r\n<p><strong>Option B</strong>: <em>Doxorubicin is the Anthracycline anticancer drugs that have the highest risk of cardiac toxicity, it can cause a <strong>dose dependent dilated cardiomyopathy associated with a potentially fatal cardiac failure</strong></em></p>\r\n<p><strong>Option C</strong><em>: Vincristine is associated with development of <strong>peripheral neuropathy</strong> in first few weeks of therapy characterised by paresthesias and loss of reflexes</em></p>\r\n<p><strong><u>Key takeaway</u></strong></p>\r\n<ul>\r\n<li><strong><em>Among the anticancer drugs, bleomycin most commonly causes pulmonary toxicity, mainly interstitial pneumonitis followed by pulmonary fibrosis. The mortality associated with bleomycin pulmonary toxicity is very high (about 50%).</em></strong></li>\r\n</ul>",
      "correct_choice_id": 154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Clomiphene</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Leuprolide</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Trastuzumab</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Flutamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 63-year-old woman complained to her physician of intermittent back pain that's worse at night. History revealed that the woman had undergone a modified radical mastectomy 2 years earlier for infiltrating ductal carcinoma of the breast that turned out to be HER-2 (human epidermal growth factor receptor 2) positive. A computed tomography scan revealed bone metastases, and she was scheduled for high-dose combination chemotherapy. Which of the following drugs was most likely included in her treatment regimen?</span></p>",
      "unique_key": "DT1293612",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293612,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><em><u>Trastuzumab is a monoclonal antibody against a surface protein called human epidermal growth factor receptor 2 (HER-2), which may be overexpressed in primary breast carcinoma</u></em><em>.</em></li>\r\n<li><em>The drug binds with high affinity to this receptor, thus preventing the binding of HER to the same receptor. In this way, tumor growth is inhibited.</em></li>\r\n<li><strong><em>Trastuzumab is used in HER-2 positive, metastasized breast cancer, alone or in combination with paclitaxel</em></strong><em>.</em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412241636e560-67fc-4c0b-8bc3-f6ceaffc7dee.jpg\">\r\n<p><strong>Option A, B &amp; D</strong><em>: All of these agents are not first choice in metastatic breast cancer.</em></p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Trastuzumab is used in <strong>HER-2 positive, metastasized breast cancer, alone or in combination with paclitaxel.</strong></em></li>\r\n</ul>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Ponatinib</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Pertuzumab</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Cisplatin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Given below figure shows the mechanism of action of which of the following anti-cancer drug? <br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412243ffa055c-ca03-4fbd-9ffd-b27b2ec4c46f.jpg\"></span></p>",
      "unique_key": "DT1293614",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293614,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong><em>Tyrosine kinase activated by abl-bcr fusion result in CML. This enzyme can be inhibited by</em></strong>\r\n<ul>\r\n<li><strong><em>B</em></strong><strong><em>: Bosutinib</em></strong></li>\r\n<li><strong><em>I</em></strong><strong><em>: Imatinib</em></strong></li>\r\n<li><strong><em>N</em></strong><strong><em>: Nilotinib</em></strong></li>\r\n<li><strong><em>D</em></strong><strong><em>: Dasatinib</em></strong></li>\r\n<li><strong><em>Proteins</em></strong><strong><em>: Ponatinib&nbsp;</em></strong><strong><em>(Mnemonic: B I N D Protein)</em></strong></li>\r\n</ul>\r\n</li>\r\n<li><strong><em>Ponatinib</em></strong>\r\n<ul>\r\n<li><strong><em>Ponatinib is a third-generation BCR-ABL kinase inhibitor.</em></strong></li>\r\n<li><em><u>Imatinib (first generation) lacks efficacy for the more advanced disease phases</u></em><em>, and cells with mutations in the BCR-ABL tyrosine kinase domain are resistant.</em></li>\r\n<li><em><u>Second-generation inhibitors (nilotinib, dasatinib, bosutinib) were developed to address these weaknesses</u></em><em>, although they do not inhibit the T315I mutant of BCR-ABL that is found in 15%-20% of patients with CML.</em></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Option A, C &amp; D</strong><em>: All of these agents are not BCR-ABL kinase inhibitor</em></p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Ponatinib is a <strong>third-generation BCR-ABL kinase inhibitor</strong></em></li>\r\n</ul>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Muromonab-CD3</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Aldesleukin</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old woman who had been undergoing hemodialysis for 3 years was admitted to the hospital for a kidney transplant. Before and after surgery, she received cyclosporine, azathioprine and prednisone. Four days after surgery, she developed acute allograft rejection. High-dose prednisone failed to resolve the rejection. Which of the following drugs could be used to treat this case of steroid-resistant rejection?</span></p>",
      "unique_key": "DT1293615",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293615,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong><em>A high-dose glucocorticoid (usually intravenous methylprednisolone) is considered first-line therapy for acute rejection because it works very quickly in decreasing lymphocyte responsiveness and can reverse at least 75% of acute rejection episodes</em></strong><em>.</em></li>\r\n<li><strong><em>Muromonab-CD3 is usually reserved for steroid resistant rejection.</em></strong></li>\r\n</ul>\r\n<p><strong><em><u>Muromonab</u></em></strong><em> <strong><u>CD3</u></strong></em></p>\r\n<ul>\r\n<li><em>It is <u>now primarily used for acute transplant rejection reaction, particularly in steroid-resistant cases</u>.</em></li>\r\n<li><em>Daily i.v. injection of <u>muromonab CD3 is given for 2 weeks along with corticosteroids and other immunosuppressants</u>.</em></li>\r\n<li><em>It has also been used to deplete T cells from the donor bone marrow before transplantation.</em></li>\r\n<li><strong><em>Initial doses of muromonab CD3 are associated with</em></strong></li>\r\n<li><em>'<strong><u>Cytokine release syndrome'</u></strong><u> with flu-like symptoms, viz. chills, rigor, high fever, wheezing, malaise, etc. which is due to release of TNF&alpha;, ILs and interferon.</u></em></li>\r\n</ul>\r\n<p><strong>Option A</strong>: Because prednisone failed to resolve the rejection, administration of another steroid would be irrational.</p>\r\n<p><strong>Option C</strong>: Aldesleukin is an immunostimulant, not an immunosuppressive drug.</p>\r\n<p><strong>Option D</strong>: Because a cytotoxic drug failed to prevent rejection, the choice of other cytotoxic drugs is not appropriate.</p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Muromonab-CD3 is usually reserved for steroid resistant rejection.</em></li>\r\n</ul>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypotension</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypokalemia</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoglycemia</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Neurotoxicity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman who underwent a liver transplant started an immunosuppressive therapy that included tacrolimus. The risk of which of the following drug-related disorders were most likely increased in this patient?</span></p>",
      "unique_key": "DT1293616",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293616,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><em><u>Neurotoxicity and nephrotoxicity are the two major adverse effects of tacrolimus, occurring in more than 50% of patients receiving this drug</u></em><em>.</em></li>\r\n<li><em><u>Neurotoxicity includes headache, insomnia, tremor, paresthesias, and seizures</u></em><em>.</em></li>\r\n<li><strong><em>Side effects: 4 H</em></strong>\r\n<ul>\r\n<li><em>Hypertension</em></li>\r\n<li><em>Hirsutism</em></li>\r\n<li><em>Gum hyperplasia </em></li>\r\n<li><em>Hyperuricemia</em></li>\r\n<li><em><u>Tacrolimus is likely to precipitate diabetes, cause neurotoxicity, alopecia and diarrhoea</u></em><em>.</em></li>\r\n<li><strong><em>Dose limiting toxicity is renal.</em></strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p>Option A : Tacrolimus can cause Hypertension, Not Hypotension.</p>\r\n<p>Option B : Tacrolimus Causes Hyperkalemia, not Hypokalemia.</p>\r\n<p>Option C : Tacrolimus Can cause Hyperglycemia and Precipitate Diabetes Not Hypoglycemia.</p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><strong><em>Neurotoxicity and nephrotoxicity</em></strong><em> are the two major adverse effects of tacrolimus, occurring in more than 50% of patients receiving this drug.</em></li>\r\n</ul>",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}